Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Iván Álvarez‐Twose"'
Autor:
Aniza Giacaman, José Antonio Salinas Sanz, Mercedes Guibelalde, Iván Álvarez-Twose, Ana Martín-Santiago
Publikováno v:
Anales de Pediatría (English Edition), Vol 99, Iss 5, Pp 350-351 (2023)
Externí odkaz:
https://doaj.org/article/f31b6e8a3b6b416890e22dbfb9da218b
Autor:
Alba Pérez‐Pons, María Jara‐Acevedo, Ana Henriques, Paula Navarro‐Navarro, Andrés C. García‐Montero, Iván Álvarez‐Twose, Carlos E. Pedreira, Laura Sánchez‐Muñoz, Daniela Damasceno, Carolina Caldas, Javier I. Muñoz‐González, Almudena Matito, Juan Flores‐Montero, Oscar González‐López, Ignacio Criado, Andrea Mayado, Alberto Orfao
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 6, Pp n/a-n/a (2022)
Abstract Background Mast cells (MC) from systemic mastocytosis (SM) patients release MC mediators that lead to an altered microenvironment with potential consequences on innate immune cells, such as monocytes and dendritic cells (DC). Here we investi
Externí odkaz:
https://doaj.org/article/dd7db6ae0e5a44aeb3411ba56ebf9c86
Autor:
María González-Tablas, Carlos Prieto, Daniel Arandia, María Jara-Acevedo, Álvaro Otero, Daniel Pascual, Laura Ruíz, Iván Álvarez-Twose, Andrés Celestino García-Montero, Alberto Orfao, María Dolores Tabernero
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Human WHO grade 1 meningiomas are generally considered benign tumors; despite this, they account for ≈50% of all recurrent meningiomas. Currently, limited data exist about the mutational profiles of grade 1 meningiomas and patient outcome. We inves
Externí odkaz:
https://doaj.org/article/651bc04a5fbc4ef3baa4c70aeaba289e
Autor:
Oscar González-López, Javier I. Muñoz-González, Alberto Orfao, Iván Álvarez-Twose, Andrés C. García-Montero
Publikováno v:
Cancers, Vol 14, Iss 10, p 2487 (2022)
Systemic mastocytosis (SM) is a rare clonal haematopoietic stem cell disease in which activating KIT mutations (most commonly KIT D816V) are present in virtually every (>90%) adult patient at similar frequencies among non-advanced and advanced forms
Externí odkaz:
https://doaj.org/article/a8fb74eb0c0446109ac639b6019edc55
Autor:
Noemí Muñoz-García, María Jara-Acevedo, Carolina Caldas, Paloma Bárcena, Antonio López, Noemí Puig, Miguel Alcoceba, Paula Fernández, Neus Villamor, Juan A. Flores-Montero, Karoll Gómez, María Angelina Lemes, Jose Carlos Hernández, Iván Álvarez-Twose, Jose Luis Guerra, Marcos González, Alberto Orfao, Julia Almeida
Publikováno v:
Cancers, Vol 12, Iss 12, p 3508 (2020)
STAT3 and STAT5B (STAT3/STAT5B) mutations are the most common mutations in T-cell large granular lymphocytic leukemia (T-LGLL) and chronic lymphoproliferative disorders of NK cells (CLPD-NK), but their clinical impact remains unknown. We investigated
Externí odkaz:
https://doaj.org/article/9ff17b5fb26d4a6e80a17f80e9f166a4
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
The prevalence of anaphylaxis among patients with clonal mast cell disorders (MCD) is clearly higher comparing to the general population. Due to a lower frequency of symptoms outside of acute episodes, clonal MCD in the absence of skin lesions might
Externí odkaz:
https://doaj.org/article/b638d9fd6f9f4b0090ad6ccc88827b6c
Autor:
Noelia Dasilva-Freire, Andrea Mayado, Cristina Teodosio, María Jara-Acevedo, Iván Álvarez-Twose, Almudena Matito, Laura Sánchez-Muñoz, Carolina Caldas, Ana Henriques, Javier I. Muñoz-González, Andrés C. García-Montero, J. Ignacio Sánchez-Gallego, Luis Escribano, Alberto Orfao
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 3, p 552 (2019)
Despite recent therapeutic advances, systemic mastocytosis (SM) remains an incurable disease due to limited complete remission (CR) rates even after novel therapies. To date, no study has evaluated the expression on SM bone marrow mast cells (BMMC) o
Externí odkaz:
https://doaj.org/article/5ae0a23605d14668a5af6d489645794c
Autor:
Almudena Matito, José Mario Morgado, Iván Álvarez-Twose, Laura Sánchez-Muñoz, Carlos Eduardo Pedreira, María Jara-Acevedo, Cristina Teodosio, Paula Sánchez-López, Elisa Fernández-Núñez, Ricardo Moreno-Borque, Andrés García-Montero, Alberto Orfao, Luis Escribano
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76116 (2013)
BACKGROUND: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease beha
Externí odkaz:
https://doaj.org/article/221727acaa9e4604934729ea92d4ba2b
Autor:
Tiago Azenha Rama, Ana Filipa Henriques, Almudena Matito, Maria Jara-Acevedo, Carolina Caldas, Andrea Mayado, Javier I. Muñoz-González, André Moreira, João Cavaleiro-Rufo, Andrés García-Montero, Alberto Órfão, Laura Sanchez-Muñoz, Iván Álvarez-Twose
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 11:1536-1547
Autor:
Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H. Radia, Johannes Lübke, Priyanka J. Bobbili, Aolin Wang, Chelsea Norregaard, Saša Dimitrijevic, Erin Sullivan, Melinda Louie-Gao, Juliana Schwaab, Ilene A. Galinsky, Cecelia Perkins, Wolfgang R. Sperr, Priya Sriskandarajah, Andi Chin, Selvam R. Sendhil, Mei Sheng Duh, Peter Valent, Daniel J. DeAngelo
Publikováno v:
Leukemia. 36:2108-2120
Advanced systemic mastocytosis (AdvSM) is a rare myeloid neoplasm associated with poor overall survival (OS). This study (NCT04695431) compared clinical outcomes between patients with AdvSM treated with avapritinib in the Phase 1 EXPLORER (NCT0256198